Journal of the Neurological Sciences
Volume 206, Issue 2 , Pages 215-216 , 15 February 2003

Interferon beta-1a in primary progressive multiple sclerosis

References 

  1. Thompson AJ, Polman CH, Miller DH, et al.  Primary progressive multiple sclerosis. Brain. 1997;120:1085–1096
  2. British and Dutch Multiple Sclerosis Azathioprine Trial Group . Double-masked trial of azathioprine in multiple sclerosis. Lancet. 1988;ii:179–183
  3. Goodkin DE, Rudick RA, VanderBrug Medendorp S, et al.  Low dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann. Neurol. 1995;37:30–40
  4. Rice GPA, et al.  for the Cladribine MRI Study Group   Cladribine and progressive MS. Clinical and MRI outcomes of a multicenter controlled trial. Neurology. 2000;54:1145–1155
  5. Poehlau D, Federlein J, Postert T, et al.  Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis—outline of a double-blind randomized, placebo-controlled trial. Mult. Scler. 1997;3:149–152
  6. Leary SM, Miller DH, Stevenson VL, Brex PA, Chard DT, Thompson AJ. Interferon β-1a in primary progressive MS: an exploratory randomized controlled trial. Neurology [in press].
  7. Montalban X, Tintore M, Rio J, et al.  Primary progressive multiple sclerosis: description of 121 patients and study design of a controlled trial. Mult. Scler. 1998;4:344; [abstract]
  8. Kalkers NF, Barkhof F, Bergers E, et al. The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study. Mult. Scler. [in press].
  9. Kita M, Goodkin DE, Bacchetti P, et al.  A phase II trial of mitoxantrone in patients with primary progressive multiple sclerosis. Neurology. 2000;54(Suppl. 3):A22; [abstract]
  10. Wolinsky JS, Narayana PA  The PROMiSe Trial Study Group . Characteristics at entry into the glatiramer acetate study of primary progressive multiple sclerosis: the PROMiSe trial. J. Neurol. 2001;248(Suppl. 2):134; [abstract]
  11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983;33:1444–1452

PII: S0022-510X(02)00350-7

Journal of the Neurological Sciences
Volume 206, Issue 2 , Pages 215-216 , 15 February 2003

Article Tools